Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.94 EUR
−219.38 M EUR
80.49 M EUR
45.80 M
About REGENXBIO Inc.
Sector
Industry
CEO
Curran M. Simpson
Website
Headquarters
Rockville
Founded
2008
ISIN
US75901B1070
FIGI
BBG01BGVYJ18
REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of RB0 is 10.20 EUR — it has increased by 1.67% in the past 24 hours. Watch REGENXBIO, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange REGENXBIO, Inc. stocks are traded under the ticker RB0.
RB0 stock has risen by 12.96% compared to the previous week, the month change is a 11.59% rise, over the last year REGENXBIO, Inc. has showed a 19.30% increase.
We've gathered analysts' opinions on REGENXBIO, Inc. future price: according to them, RB0 price has a max estimate of 44.30 EUR and a min estimate of 11.93 EUR. Watch RB0 chart and read a more detailed REGENXBIO, Inc. stock forecast: see what analysts think of REGENXBIO, Inc. and suggest that you do with its stocks.
RB0 stock is 13.97% volatile and has beta coefficient of 2.57. Track REGENXBIO, Inc. stock price on the chart and check out the list of the most volatile stocks — is REGENXBIO, Inc. there?
Today REGENXBIO, Inc. has the market capitalization of 455.49 M, it has increased by 11.04% over the last week.
Yes, you can track REGENXBIO, Inc. financials in yearly and quarterly reports right on TradingView.
REGENXBIO, Inc. is going to release the next earnings report on Nov 5, 2025. Keep track of upcoming events with our Earnings Calendar.
RB0 earnings for the last quarter are −1.17 EUR per share, whereas the estimation was −0.80 EUR resulting in a −47.14% surprise. The estimated earnings for the next quarter are −1.11 EUR per share. See more details about REGENXBIO, Inc. earnings.
REGENXBIO, Inc. revenue for the last quarter amounts to 18.13 M EUR, despite the estimated figure of 32.85 M EUR. In the next quarter, revenue is expected to reach 20.56 M EUR.
RB0 net income for the last quarter is −60.16 M EUR, while the quarter before that showed 5.62 M EUR of net income which accounts for −1.17 K% change. Track more REGENXBIO, Inc. financial stats to get the full picture.
No, RB0 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 8, 2025, the company has 353 employees. See our rating of the largest employees — is REGENXBIO, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. REGENXBIO, Inc. EBITDA is −126.28 M EUR, and current EBITDA margin is −258.05%. See more stats in REGENXBIO, Inc. financial statements.
Like other stocks, RB0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REGENXBIO, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So REGENXBIO, Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating REGENXBIO, Inc. stock shows the buy signal. See more of REGENXBIO, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.